glp-1 supply expansion news today Agonists Weight Loss Drugs Market Report, 2025-2030 GLP-1 Receptor Agonist Market Size
Description
Practice points are consensus statements about a specific aspect of care and represent the expert judgment of the guideline work group, but may also be based on limited evidence (not graded for strength or quality of evidence)

The post-discontinuation phase remains the least investigated, although extension studies consistently show that weight regain occurs rapidly, with patients regaining up to two-thirds of the lost weight within one year after withdrawal (22)

NCHS Data Brief (2020) 360):18

How GLP-1 Medications Support Weight Loss Understanding how these medications work helps set realistic expectations and empowers patients to maximize their treatment success

Your PlexusDx clinician can assess your individual risk profile and recommend timing adjustments, alternative birth control methods, or monitoring strategies tailored to your medication regimen

The missed dose protocols for Ozempic and Wegovy are slightly different, and understanding them helps you make better decisions about early dosing too
